|
|
 |
|
Viewing report
|
|
|
|
Development and Evaluation of Drugs: From Laboratory through Licensure to Market
Informa Healthcare, July 1993, Pages: 240
Development and Evaluation of Drugs presents a comprehensive description of the development and evaluation of drugs and provides valuable information that will help you understand the regulatory processes of government agencies, especially the U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health and Welfare. The book also analyzes various problems of manufacturing practices in the pharmaceutical industry, discusses aspects of drug interactions and responses, and examines methods for promoting health and preventing diseases. Development and Evaluation of Drugs will be excellent for investigators in medical research and pharmaceutics. It will also be useful to health scientists, managers, and personnel in regulatory agencies.
Features
Customers who bought this item also bought
Innovation, Health Technology Assessment, and Comparative Effectiveness Research: The Obstacle Course to Market Access
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure
Rx Marketer’s Reference Guide, 2nd Edition Report Information
Healthcare Reform in China
Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform and the Inter-linkages Bringing them Together
Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality
Advances in Drug-Diagnostic Co-Development
Market Access, Pricing, and Reimbursement News in the First Quarter of 2009
Pharmaceutical Management of Obesity
Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs
|
|
|
|
